when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

ELREXFIO (ELRANATAMAB) — FDA approval

February 19, 2026$PFE elranatamabupdated 5mo ago

community read0 votes

Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 7

phase 3 completionCellCarta Biosciences Inc — elranatamab (Phase III Trial Completion)Apr 27, 2026 · 163d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalMar 25, 2026 · 196d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 10, 2025 · 454d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 8, 2025 · 456d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalSep 10, 2024 · 757d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalDec 13, 2023 · 1029d ago
approvalELREXFIO (ELRANATAMAB) — FDA approvalAug 14, 2023 · 1150d ago

same company · ±60 days · 6

recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026
recallF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)Feb 18, 2026

🐶 often sniffed alongside

top 6

drugELREXFIO29 co-mentions · 8 sources
tagApproval28 co-mentions · 7 sources
company$PFEPFIZER INC14 co-mentions · 7 sources
tagMultiple Myeloma3 co-mentions · 1 sources
companyCellCarta Biosciences Inc1 co-mentions · 1 sources
tagOncology1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?